Antibodies Inhibiting the Type III Secretion System of Gram-Negative Pathogenic Bacteria
Pathogenic bacteria are a global health threat, with over 2 million infections caused by Gram-negative bacteria every year in the United States. This problem is exacerbated by the increase in resistance to common antibiotics that are routinely used to treat these infections, creating an urgent need...
Hlavní autoři: | Julia A. Hotinger, Aaron E. May |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
MDPI AG
2020-07-01
|
Edice: | Antibodies |
Témata: | |
On-line přístup: | https://www.mdpi.com/2073-4468/9/3/35 |
Podobné jednotky
-
Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components
Autor: Julia A. Hotinger, a další
Vydáno: (2021-02-01) -
Animal Models of Type III Secretion System-Mediated Pathogenesis
Autor: Julia A. Hotinger, a další
Vydáno: (2019-11-01) -
Natural Product Type III Secretion System Inhibitors
Autor: Heather A. Pendergrass, a další
Vydáno: (2019-09-01) -
The Case against Antibiotics and for Anti-Virulence Therapeutics
Autor: Julia A. Hotinger, a další
Vydáno: (2021-09-01) -
Aurodox inhibits type III secretion in multiple Gram-negative pathogens
Autor: David R. Mark, a další
Vydáno: (2024-11-01)